MONITOR YOUR BLOOD GLUCOSE

NO NEEDLES

CGM that does not compromise your comfort

Safe

Needle-free means no pain, no inflammation

Compact

Small enough to wear comfortably, like a smartwatch

Delivers the same accuracy as traditional CGMs

Accurate

Affordable

Over 50% cheaper annually—no sensor replacements needed

MOGLU

Needle Gone, Data On

Our technology uses Raman spectroscopy to target key glucose signals, eliminating the need for full-spectrum analysis and allowing us to minimize device size.

MOGLU’s design features narrow filters and high-sensitivity photodiodes, enhancing signal-to-noise ratio (SNR) and energy efficiency while reducing dark noise. The 830 nm laser directly measures glucose levels in the body, providing precise results within FDA standards without skin irritation, making MOGLU more accurate and comfortable than traditional methods.

TEAM

Aram Hong, MPP

CEO & Co-founder

Miyeon Jue, Ph.D.

CTO & Co-founder

Optical Engineer

Arianna Bresci, Ph.D.

Optical Engineer

Junhyeok Jeong, MS

Optical Engineer

Daeyeong Choi, MS

Hardware Engineer

Minkyung Seo

Software Engineer

Jeon Woong Kang, Ph.D.

Scientist, MIT

Youngkyu Kim, Ph.D.

Vijay Rah Signh, Ph.D.

ADVISORS & COLLABORATORS

Jun Ki Kim, Ph.D.

Co-Founder & Professor, Asan Medical Center

Professor, MIT

Peter So, Ph.D.

CAREERS

At Apollon, we're revolutionizing diabetes care with needle-free continuous glucose monitoring, powered by cutting-edge Raman spectroscopy. Founded in Seoul and Boston, with ongoing clinical trials at MIT, we're more than a startup - we're a movement to transform lives.

Join our team of world-class experts and contribute directly to groundbreaking medical technology. We're seeking innovators, visionaries, and problem-solvers ready to push the boundaries of what's possible in medtech. Your expertise could help make diabetes management painless, affordable, and accessible globally.

Are you ready to shape the future of healthcare? Your journey begins at Apollon.

Open Position